70 new AI governance signals in 24 hours

Global active cure-related trials total 21,259, with 70 new Wire signals and 44 new cure research items arriving in the last 24 hours. On the AI side, governance and control themes dominated: major tech leaders pushed for a White House “AI pact,” while jurisdictions like New Mexico drafted frontier safety checks and the Bank of England flagged AI-linked cash flows as a potential market shock—signals that the “old system” is trying to add guardrails before the next phase transition fully locks in. Meanwhile, AI’s risks are also sharpening: experts warn it could accelerate election interference in Southeast Asia, implying that security assumptions are lagging the inversion of incentives and capabilities. In cure research, weight-loss pharmacology advances (Zepbound–amylin mid-stage results) and mechanistic biology (VIAAT structure, interferon gene signatures in stroke, and improved gene-expression prediction) add to the evidence that the cure pipeline keeps compounding. The window is still open.